Beta Drugs Ltd

beta drugs limited

About the Company:

Beta Drugs Limited is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic & international customers. .

Company’smanufacturing unit is an ISO 9001:2008 certified facility located at Kharuni –Lodhimajra Road, Village Nandpur, Baddi, Dist-Solan Himachal Pradesh, and India.

Company is primarily engaged in the manufacturing of oncology products.Company’s products range from anti-cancer tablets, capsules, injections and lyophilized injections.

Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease.

As on March 31, 2017, Company had a portfolio of over 50 products catering to various oncology diseases.

Company has increased their product range, starting from 35 in 2015-16 to 50 active products in 2016-17.Company’s oncology portfolio includes key brands like Admine, Adgef, Addplatin, Erlotad etc.


Management Team:

  1. Mr.Vijay Kumar Batra (Designation: Managing Director)
  2. Mr.Balwant Singh (Designation: Whole Time Director)
  3. Mr.Varun Batra (Designation: Whole Time Director)


Promoters Average Acquisition Cost:

Name of the Promoter No. of Shares held Average Acquisition Cost (in Rs.)
Vijay Batra 5924780 1.80


Promoters Stake Pre & Post Issue:

Shareholder Name Pre Issue Stake (%) Post Issue Stake
Vijay Batra 93.25% 68.50%
Promoter Group Entities             0.53%           0.39%
Total 93.78% 68.89%


Objectives of the Issue:

  • Purchase of new plant and machinery and upgradation of company’s existing plant and machinery.
  • Civil Construction work at existing manufacturing unit.
  • To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme certificate.
  • Working Capital requirements.
  • General Corporate Purpose.


Fund Utilization:

Particulars Amount (Rs. in Crores)
Purchase of new plant and machinery and upgradtion
of our existing plant and machinery
Civil Construction work at existing manufacturing unit. 1.27
To obtain registration of European Union GMP &
Pharmaceutical Inspection Co-operation Scheme.
Working Capital 2.94
General Corporate Purpose* 4.09
Net Proceeds 16.5


Check IPO Allotment Status:

Link Time Website


Financials of the Company:

(in Crores) FY 13 FY 14 FY 15 FY 16 FY 17
Revenue 3.12 1.38 0.26 26.39 41.68
Net Profit 0.04 0.02 0.11 1.13 5.17


Valuation of Peer Group Companies:

Company Name Face Value CMP EPS PE Ratio RoNW NAV
Beta Drugs
10 85 8.69 9.78 70.18 12.39
10 91.90 4.14 22.20 1.04 370.41
2 726.20 28.27 25.69 29.11 97.40


IPO Details:

Details Info
Issue Opens on 29th September 2017
Issue Closes on:. 4th October 2017
Issue Price Rs.85
Face Value Rs.10
Minimum Lot 1600
Minimum Investment Rs.1,36,000
Issue Constitutes 26.54%
Issue Size Rs.19.51 cr
Market Cap Rs.73.52 cr
Listing at NSE SME
Equity Shares Offered (Fresh) 22,96,000
Equity Shares Prior 63,35,500
Equity Shares after the issue 86,49,500


Important Dates:

Finalization of Basis of Alottment on or Before 9th October 2017
Initiation of Refunds on or Before 10th October 2017
Credit of Equity Shares: on or Before 11th October 2017
Listing Date: on or Before 12th October 2017


IPO Valuation Parameters:

Earnings Per Share (EPS) Price To Earnings ratio (PE) Return on Net Worth (RoNW) Net Asset Value (NAV)
8.69 9.78 50.48% 12.39


Markets Guruji Opinion:

IPO View Apply For: Expected listing Gain:
Subscribe Short Term 10%